— Know what they know.
Not Investment Advice

ZYME NASDAQ

Zymeworks Inc.
1W: +4.8% 1M: -12.0% 3M: +10.5% YTD: -5.7% 1Y: +102.0% 3Y: +178.1% 5Y: -12.2%
$25.61
+0.50 (+1.99%)
 
Weekly Expected Move ±6.9%
$21 $22 $24 $26 $27
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 36 · $1.9B mcap · 68M float · 0.983% daily turnover · Short 62% of daily vol

Balance Sheet Trends

Total Assets
$347M -25.2% ▼
5Y CAGR: -8.4%
Total Liabilities
$78M -37.2% ▼
5Y CAGR: -9.5%
Shareholders Equity
$269M -20.7% ▼
5Y CAGR: -8.1%
Cash & Investments
$229M +1.3% ▲
5Y CAGR: -11.7%
Total Debt
$18M -1.3% ▼
5Y CAGR: +16.1%
Net Debt
-$23M +51.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$202M$401M$158M$66M$41M
Short-Term Investments$51M$91M$217M$160M$188M
Cash & ST Investments$253M$492M$374M$226M$229M
Net Receivables$16M$33M$19M$56M$5M
Inventory$0$0$0$0$0
Other Current Assets$0$19M$19M$19M$0
Total Current Assets$288M$545M$413M$300M$233M
Property, Plant & Equip.$50M$48M$38M$34M$0
Goodwill & Intangibles$33M$38M$37M$17M$13.4B
Long-Term Investments$886K$886K$82M$98M$42M
Other Non-Current Assets$14M$16M$8M$9M-$13.3B
Total Non-Current Assets$101M$104M$168M$163M$113M
Total Assets$389M$649M$581M$463M$347M
— Liabilities —
Accounts Payable$5M$8M$6M$4M$36M
Short-Term Debt$0$0$0$0$3M
Deferred Revenue$0$2M$4M$26M$0
Other Current Liabilities$11M$16M$9M$7M$3M
Total Current Liabilities$72M$96M$56M$88M$42M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$3M$3M$2M$895K$278K
Total Non-Current Liabilities$68M$60M$60M$36M$36M
Total Liabilities$140M$156M$116M$124M$78M
— Equity —
Common Stock$741M$907M$1.0B$1.0B$1.1B
Retained Earnings-$683M-$559M-$677M-$830M-$953M
Accumulated OCI-$7M-$7M-$7M-$7M-$6M
Total Stockholders Equity$249M$493M$465M$339M$269M
Total Liabilities & Equity$389M$649M$581M$463M$347M
— Key Metrics —
Total Debt$32M$28M$27M$19M$18M
Net Debt-$170M-$373M-$131M-$48M-$23M
Total Investments$52M$92M$299M$258M$229M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms